Limitations, agreements, and source contact

Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma · Source last updated 2026-02-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

true

point Of Contact

email

Mesoprime.Trial@rmh.nhs.uk

organization

The Royal Marsden NHS Foundation Trust

phone

(+44)2089156666

title

MESO-PRIME Trial Manager

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice